| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.49B | 54.83B | 48.90B | 45.30B | 37.01B | 25.84B |
| Gross Profit | 24.69B | 21.12B | 18.41B | 16.76B | 12.13B | 6.42B |
| EBITDA | 12.59B | 12.28B | 11.02B | 9.31B | 6.19B | 1.43B |
| Net Income | 7.85B | 7.90B | 7.89B | 6.06B | 3.42B | -143.04M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 72.65B | 56.25B | 41.62B | 31.30B | 27.70B |
| Cash, Cash Equivalents and Short-Term Investments | 16.27B | 16.27B | 11.04B | 6.51B | 3.01B | 2.39B |
| Total Debt | 0.00 | 24.28B | 16.27B | 8.84B | 7.23B | 8.26B |
| Total Liabilities | -36.28B | 36.37B | 27.39B | 20.30B | 16.40B | 16.49B |
| Stockholders Equity | 36.28B | 36.26B | 28.84B | 21.31B | 14.89B | 11.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -961.81M | 959.93M | 5.63B | 2.34B | 2.39B |
| Operating Cash Flow | 0.00 | 9.86B | 10.67B | 10.85B | 4.85B | 3.09B |
| Investing Cash Flow | 0.00 | -13.25B | -14.58B | -11.74B | -2.67B | -1.13B |
| Financing Cash Flow | 0.00 | 5.44B | 4.88B | 877.41M | -1.59B | -1.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹711.95B | 18.87 | ― | 0.33% | 7.33% | -3.79% | |
71 Outperform | ₹361.40B | 75.82 | ― | 0.24% | 14.72% | 8.37% | |
67 Neutral | ₹81.00B | -247.47 | ― | ― | 17.58% | -38.20% | |
65 Neutral | ₹281.58B | 114.01 | ― | ― | 25.74% | 1.41% | |
65 Neutral | ₹298.69B | 83.79 | ― | 0.04% | 15.78% | 15.01% | |
61 Neutral | ₹695.24B | 86.12 | ― | 0.11% | 15.33% | 54.62% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Narayana Hrudayalaya has scheduled meetings of its shareholders and secured and unsecured creditors, alongside those of NH Integrated Care Private Limited, on 2 April 2026 via video conferencing, as directed by the National Company Law Tribunal in Bengaluru. The meetings will vote on a Scheme of Arrangement under the Companies Act that will govern the proposed restructuring between the demerged NH Integrated Care and Narayana Hrudayalaya as the resulting company.
The company has set a remote e-voting window from 30 March to 1 April 2026 to enable stakeholders to cast votes on the scheme ahead of the meetings, and has circulated the notices electronically and by post where needed. The process marks a key step in formalising the corporate reorganisation, with outcomes likely to influence Narayana Hrudayalaya’s capital structure and its future integration with NH Integrated Care, with implications for both creditors and equity holders.
Narayana Hrudayalaya Ltd. has scheduled meetings of its shareholders and secured and unsecured creditors, along with those of NH Integrated Care Private Limited, on April 2, 2026, following directions from the National Company Law Tribunal’s Bengaluru Bench. These meetings, to be held via video conferencing or other audio-visual means, will vote on a Scheme of Arrangement under the Companies Act that contemplates NH Integrated Care as the demerged entity and Narayana Hrudayalaya as the resulting company.
The company has outlined a detailed timetable, with separate sessions for equity shareholders, secured creditors, and unsecured creditors of both Narayana Hrudayalaya and NH Integrated Care, and has enabled remote e-voting from March 30 to April 1, 2026. By moving the process forward under the oversight of the NCLT and providing multiple participation channels and advance dispatch of notices, the company is progressing toward a corporate restructuring that could realign its integrated care business within the broader Narayana Health group structure, potentially affecting capital structure and stakeholder claims once approved.
Narayana Hrudayalaya Limited, a leading hospital and healthcare services provider, operates through a network of medical institutions and subsidiaries across India, offering a range of clinical and research-focused healthcare services.
The company has announced that, pursuant to an order of the National Company Law Tribunal (NCLT) Bengaluru Bench dated 30 January 2026, it has published a statutory NCLT-3A advertisement detailing a petition for the proposed amalgamation of its subsidiary Meridian Medical Research & Hospital Ltd. with Narayana Hrudayalaya Limited. The notice, carried in Business Standard (all-India, English) and Kannada Prabha (Karnataka, Kannada) on 7 February 2026, provides information on the merger petition and the scheduled NCLT hearing on 27 February 2026, marking a key procedural step in consolidating the subsidiary into the parent company and potentially streamlining the group’s hospital and research operations.
Narayana Hrudayalaya Limited has reported the voting results and Scrutinizer’s Report for National Company Law Tribunal-convened meetings of its equity shareholders, secured creditors, unsecured loan creditors and unsecured trade creditors held on 19 January 2026 via video conferencing, in line with SEBI disclosure requirements. The stakeholders overwhelmingly approved a special resolution for a Scheme of Arrangement between Meridian Medical Research & Hospital Ltd as transferor company and Narayana Hrudayalaya Limited as transferee company under Sections 230–232 of the Companies Act, 2013, with near-unanimous e-voting support across promoter, institutional and non-institutional categories; the outcome, now disclosed to stock exchanges and on the company and NSDL websites, clears a key procedural hurdle for the proposed restructuring, potentially strengthening Narayana Hrudayalaya’s hospital portfolio and consolidating its presence in the healthcare services market, subject to remaining regulatory and tribunal approvals.
Narayana Hrudayalaya Ltd. has incorporated a new wholly owned subsidiary, Narayana Healthcare North Private Limited, with an authorised capital of Rs 10 lakh and paid-up capital of Rs 5 lakh, to operate in the hospital and healthcare sector. The subsidiary has been set up to carry on healthcare services, including hospital operations and health and wellness management, and is intended to serve as a focused vehicle to deepen and optimize the company’s growing presence in northern India, potentially strengthening its regional positioning and operational focus in that market.
Narayana Hrudayalaya Ltd. has approved a Scheme of Arrangement for the demerger of its Clinical Services undertaking from NH Integrated Care Private Limited to Narayana Hrudayalaya Limited. This strategic move is aimed at enhancing shareholder value by allowing NHIC to focus on its preventive healthcare business while optimizing patient care and resource efficiency through integrated operations within NHL. The demerger is subject to necessary statutory and regulatory approvals, including those from the National Company Law Tribunal and other relevant authorities.
Narayana Hrudayalaya Ltd. has approved a Scheme of Arrangement involving the demerger of its Clinical Services from NH Integrated Care Private Limited into Narayana Hrudayalaya Limited. This strategic move aims to enhance operational efficiency by unifying patient care pathways and optimizing resource deployment. The demerger is expected to allow NH Integrated Care to focus on its preventive healthcare business, potentially increasing shareholder value by concentrating on this niche market.